Our vision is to be the accepted PAIONeer in sedation and anesthesia; helping advance patient care.
- Media and Investors »
- Newsroom »
- Ad-hoc Releases
-
04/08/2019 12:48
PAION announces submission of new drug application for remimazolam by its Licensee Cosmo Pharmaceuticals in the U.S.